Treatment with the CHK1/2 inhibitor PF-0477736 as single agent induced cell death by apoptosis at nanomolar concentrations in DDR positive DLBCL cell lines and markedly inhibited cell viability in primary DLBCL and BL cells. Here, CHEK1 is linked to diffuse large B-cell lymphoma.